Subscribe
Sign in
Home
Events Roundup
Healthtech Pigeon
About us at SomX
Archive
About
Latest
Top
Discussions
#105 - Tick-borne nairoviruses & nuclear nibbling
The coffee break biotech roundup, by SomX.
Jul 18
•
Daisy Makin
and
Belle Taylor
1
#104 - Cockroach commandos, psychedelic solutions and mousey miracles
The coffee break biotech roundup, by SomX.
Jul 11
•
Daisy Makin
and
Andrew
2
#103 - Base edits, Beeline's billions & a global biotech kickoff
The coffee break biotech roundup, by SomX.
Jul 4
•
Daisy Makin
1
June 2026
#102 - Gut goo, nerve glue and an eye drug debut
The coffee break biotech roundup, by SomX.
Jun 27
•
Andrew
,
Daisy Makin
, and
Belle Taylor
2
#101 - Raisin remedies, rebates & reptilian repair
The coffee break biotech roundup, by SomX.
Jun 20
•
Daisy Makin
and
Belle Taylor
1
#100 - Pre-emptive pandemic jabs & coffee-controlled cells
The coffee break biotech roundup, by SomX.
Jun 13
•
Belle Taylor
,
Andrew
, and
Daisy Makin
#99 - Plastic hearts, premium China & post-mouse medicine
The coffee break biotech roundup, by SomX.
Jun 6
•
Daisy Makin
May 2026
#98 - Synthetic sperm, smart baby scans and survival shots
The coffee break biotech roundup, by SomX.
May 30
•
Belle Taylor
and
Andrew
1
#97 - Synthetic scientists, spiral peptides & space servers
The coffee break biotech roundup, by SomX.
May 23
•
Daisy Makin
and
Belle Taylor
2
#96 - Pathology platforms, pumped-up funding rounds & pelagic collagen
The coffee break biotech roundup, by SomX.
May 16
•
Daisy Makin
,
Belle Taylor
, and
Andrew
4
#95 - Plasma peanuts, Pfizer's pitfalls & Pacific production
The coffee break biotech roundup, by SomX.
May 9
•
Daisy Makin
and
Belle Taylor
2
#94 - Bug biosecurity, brain chips and eye-boosting botanicals
The coffee break biotech roundup, by SomX.
May 2
•
Andrew
,
Daisy Makin
, and
Belle Taylor
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
